Photo by freestocks.org from Pexels

Medicine Lookup

Medical News

FDA Approves Once-Monthly Andembry for Hereditary Angioedema
FRIDAY, June 20, 2025 -- The U.S. Food and Drug Administration has approved Andembry (garadacimab-gxii) as the only treatment targeting factor XIIa for prophylactic use to prevent attacks of hereditary angioedema (HAE). According to the Mayo...
Trump Administration To End Lifeline for LGBTQ+ Youth This July
FRIDAY, June 20, 2025 — A popular crisis support line for LGBTQ+ youth and young adults is shutting down July 17, federal officials confirmed this week. The “Press 3” option on the 988 National Suicide & Crisis Lifeline, which...
FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo
FRIDAY, June 20, 2025 — A new shot to prevent HIV infection has just been approved — and it only needs to be taken twice a year. On Wednesday, the U.S. Food and Drug Administration (FDA) approved lenacapavir, a long-acting injection...

Dementia Caregivers Have Modifiable Risk Factors Increasing Their Own Risk
FRIDAY, June 20, 2025 -- Six in 10 dementia caregivers report having at least one modifiable risk factor that could increase their own chances of developing dementia, according to a report issued June 12 by the Alzheimer's Association.The analysis...
FDA Approves Twice-Yearly Yeztugo for Preexposure Prophylaxis to Cut HIV Risk
FRIDAY, June 20, 2025 -- The U.S. Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as preexposure prophylaxis (PrEP) to reduce the risk for sexually acquired HIV.The approval is for adults and...
Semaglutide Offers Cardiovascular Edge Over Empagliflozin in Type 2 Diabetes
FRIDAY, June 20, 2025 -- For patients aged 45 years or older with type 2 diabetes, semaglutide seems to confer some advantage over empagliflozin in terms of mortality and cardiovascular event risks, according to a study published online June 17 in...

FDA Adds Warning About Serious Risk of Heat-Related Complications With Antinausea Patch Transderm Scōp (scopolamine transdermal system)
Audience: Consumer, Health Care Professional June 18, 2025 FDA Drug Safety Communication What safety concern is FDA announcing? The U.S. Food and Drug Administration (FDA) is warning that the antinausea patch Transderm Scōp (scopolamine...
Church & Dwight Issues Voluntary Nationwide Recall of Zicam Cold Remedy Nasal Swabs, Zicam Nasal AllClear Swabs, and Orajel Baby Teething Swabs Due to Microbial Contamination
Audience: Consumer June 06, 2025 -- Church & Dwight Co., Inc. is voluntarily recalling all lots within expiry of Zicam® Cold Remedy Nasal Swabs, Zicam® Nasal AllClear Swabs, and Orajel™ Baby Teething Swabs to the consumer level...
Amneal Pharmaceutical LLC Issues a Nationwide Recall of Sulfamethoxazole / Trimethoprim Tablets, USP, 400 mg/80 mg Only, Due to Microbial Contamination
Audience: Consumer, Pharmacy, Health Care Professional June 02, 2025 -- Amneal Pharmaceutical LLC, is recalling three lots of Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg to the consumer level as the tablets may exhibit black spots on...